Skip to main content
Clinical Trials/NCT04962607
NCT04962607
Active, not recruiting
Not Applicable

Effectiveness of Premixed Bioactive Bioceramic MTA (Neo-Putty®) Versus Formocresol as Dressing Agents in Pulpotomized Primary Molars

Hadassah Medical Organization1 site in 1 country50 target enrollmentSeptember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulpotomies on Primary Molars
Sponsor
Hadassah Medical Organization
Enrollment
50
Locations
1
Primary Endpoint
Success rate of the primary molar pulpotomy
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

The objective of this prospective randomized clinical trial is to assess clinically and radiographically, the effect of NeoPutty as a pulp medicament following coronal pulp amputation in human primary molars with carious pulp exposure in comparison to Formocresol (FC).

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
January 1, 2026
Last Updated
10 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • primary teeth which requires pulpotomy.

Exclusion Criteria

  • not healthy patients,
  • teeth which requires pulpectomy.

Outcomes

Primary Outcomes

Success rate of the primary molar pulpotomy

Time Frame: One year

Study Sites (1)

Loading locations...

Similar Trials